Table 5.
Resistant patterns of bacterial isolates.
| Isolates | Antibiotics tested | ||||||
|---|---|---|---|---|---|---|---|
| CRO | SXT | E | AM | CIP | OX | GM | |
| Gram positive bacteria | |||||||
| S. aureus (%), n = 20 | 18 (90) | 15 (75) | 17 (85) | 20 (100) | 10 (50) | 20 (100) | 15 (75) |
| CoNS (%), n = 7 | 4 (57.14) | 0 | 2 (28.57) | 7 (100) | 0 | 3 (42.86) | 0 |
| Enterococci ssp (%), n = 5 | 3 (60) | 3 (60) | 2 (40) | 0 | 2 (40) | 3 (60) | 3 (60) |
| Total (%), n = 32 | 25 (78.13) | 18 (56.25) | 21(65.63) | 27 (84.38) | 12 (37.5) | 26 (81.25) | 18 (56.25) |
| Gram negative bacteria | |||||||
| Klebsiella spp (%), n = 27 | 23 (85.19) | 22 (81.48) | NT | 27 (100) | 15 (55.56) | NT | 22 (81.48) |
| Proteus spp(%), n = 11 | 9 (81.82) | 10 (90.91) | NT | 11 (100) | 7 (63.64) | NT | 9 (81.82) |
| E. coli (%), n = 9 | 9 (100) | 9 (100) | NT | 9 (100) | 7 (77.78) | NT | 7 (77.78) |
| Enterobacter spp (%), n = 3 | 3 (100) | 3 (100) | NT | 3 (100) | 2 (66.67) | NT | 2 (66.67) |
| Serratia spp (%), n = 2 | 2 (100) | 2 (100) | NT | 2 (100) | 2 (100) | NT | 2 (100) |
| UGN (%), n = 9 | 8 (88.89) | 8 (88.89) | NT | 9 (100) | 6 (66.67) | NT | 7 (77.78) |
| Total (%), n = 61 | 54 (88.52) | 54 (88.52) | NT | 61 (100) | 39 (63.93) | NT | 49 (80.33) |
Key: CRO-ceftriaxone, SXT-sulphamethoxazole/trimethoprim (cotrimoxazole), E-erythromycin, AM-ampicillin, CIP-ciprofloxacin, OX-oxacillin, GM-gentamicin, CoNS-coagulase negative Staphylococci, Spp-species, UGN-unidentified Gram negative bacilli, NT-not tested.